3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone

Synonym
Product Category
Product Code
CAS Number
MDL Number
Pubchem CID
Reaxys RN
Tedizolid, DA 715, TR 700, Torezolid
API & Intermediates
KAPI1F10
856866-72-3
MFCD19442562
11234049
10589936
image-155171-Trimethyl(trifluoromethyl)silane_reagent.png
Chemical Name
Molecular Formula
Molecular Weight
Assay
Appearance
Melting Point
Packaging
Storage
3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone
C17H15FN6O3
370.34
≥99.8%(HPLC)
White Solid
199-201°C
500mg,1g,10g,25g,50g,100g and 500g
-20°C Freezer
Tedizolid (also known as DA 715, TR 700, Torezolid) is a novel orally and intravenously administered intracellular antibacterial agent, which is a second generation oxazolidinone derivative that is 4-to-16-fold more potent against staphylococci and enterococci compared to linezolid.
In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent. [1]
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. [2]
Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate. [3]
Comparative Efficacies of Tedizolid Phosphate, Vancomycin, and Daptomycin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis. [4]
Comparative Efficacies of Tedizolid Phosphate, Linezolid, and Vancomycin in a Murine Model of Subcutaneous Catheter-Related Biofilm Infection Due to Methicillin-Susceptible and -Resistant Staphylococcus aureus. [5]
Effects of Tedizolid Phosphate on Survival Outcomes and Suppression of Production of Staphylococcal Toxins in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia. [6]
In vitro activity of tedizolid against the Mycobacterium abscessus complex. [7]
In vitro activities of miltefosine and antibacterial agents from macrolide, oxazolidinone, and pleuromutilin classes against Pythium insidiosum and Pythium aphanidermatum. [8]
Dissemination of Staphylococcus epidermidis ST22 With Stable, High-Level Resistance to Linezolid and Tedizolid in the Greek-Turkish Region (2008-2016). [9]
References:
[1] R.Schaadt, et al, Antimicrob. Agents Chemother., 2009, 53(8), pp 3236-3239.
[2] S.Lemaire, et al, J. Antimicrob. Chemohter., 2009, 64(5), pp 1035-1043.
[3] V.Ong, et al, Drug Metab. Dispos., 2015, 42(8), pp 1275-1284.
[4] L.C.Chan, et al, Antimicrob. Agents Chemother., 2015, 59(6), pp 3252-3256.
[5] A.S.Bayer, et al, Antimicrob. Agents Chemother., 2016, 60(8), pp 5092-5096.
[6] V.T.Le, et al, Antimicrob. Agents Chemother., 2017, 61(4), pp e02734-02716.
[7] F.Compain, et al, Diagn. Microbiol. Infect. Dis., 2018, 90(3), pp 186-189.
[8] E.S.Loreto, et al, Antimicrob. Agents Chemother., 2018, 62(3), pp e01678-e01617.
[9] A.R.Freitas, et al, Infect. Control Hosp. Epidemiol., 2018, 39(4), pp 492-294.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Not a dangerous goods



NONH for all modes of transport
Sales restrictions may apply.
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.